Home » FDA Clears Apira Science’s iGROW Hair Growth Platform
FDA Clears Apira Science’s iGROW Hair Growth Platform
Apira Science, Inc., a global leader in aesthetic light-based therapies, today announced that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for its iGrow® Hair Growth Platform. This patented red light technology device is now FDA cleared for the treatment of androgenetic alopecia (male pattern hair loss).
Marketwire
Marketwire
Upcoming Events
-
07May
-
14May
-
30May